Organometallic half-sandwich iridium anticancer complexes

Publication date

2011

Authors

Liu, Z.
Habtemariam, A.
Pizarro, A.M.
Fletcher, S.A.
Kisova, A.
Vrana, O.
Salassa, L.
Bruijnincx, PieterISNI 0000000389623396
Clarkson, G.J.
Brabec, V.

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

Abstract

The low-spin 5d6 IrIII organometallic half-sandwich complexes [(η5-Cpx)Ir(XY)Cl]0/+, Cpx = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cpxph), or tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), XY = 1,10-phenanthroline (4−6), 2,2′-bipyridine (7−9), ethylenediamine (10 and 11), or picolinate (12−14), hydrolyze rapidly. Complexes with N,N-chelating ligands readily form adducts with 9-ethylguanine but not 9-ethyladenine; picolinate complexes bind to both purines. Cytotoxic potency toward A2780 human ovarian cancer cells increases with phenyl substitution on Cp*: Cpxbiph > Cpxph > Cp*; Cpxbiph complexes 6 and 9 have submicromolar activity. Guanine residues are preferential binding sites for 4−6 on plasmid DNA. Hydrophobicity (log P), cell and nucleus accumulation of Ir correlate with cytotoxicity, 6 > 5 > 4; they distribute similarly within cells. The ability to displace DNA intercalator ethidium bromide from DNA correlates with cytotoxicity and viscosity of Ir−DNA adducts. The hydrophobicity and intercalative ability of Cpxph and Cpxbiph make a major contribution to the anticancer potency of their IrIII complexes.

Keywords

SDG 3 - Good Health and Well-being

Citation

Liu, Z, Habtemariam, A, Pizarro, A M, Fletcher, S A, Kisova, A, Vrana, O, Salassa, L, Bruijnincx, P C A, Clarkson, G J, Brabec, V & Sadler, P J 2011, 'Organometallic half-sandwich iridium anticancer complexes', Journal of Medicinal Chemistry, vol. 54, no. 8, pp. 3011-3026. https://doi.org/10.1021/jm2000932